Adverse effects associated with SonoVue^® use

Bibliography

• REINHOLD C, HAMMERS L,TAYLOR CR, QUEDENS-CASE CL, HOLLAND CK, TAYLOR KJ: Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients. AIR Am. J. Roentgenol (1995) 164:1131–1135.
   PubMed Web of Science ®Google Scholar
• LEE MG, AUH YH, CHO KS, CHUNG YH, LEE IC, KANG EM: Color Doppler flow imaging of hepatocellular carcinomas: comparison with metastatic tumors and hemangiomas by three step grading color hues. Clin. Imaging (1996) 20:199–203.
   PubMed Web of Science ®Google Scholar
• WUN YT, DICKINSON JA: Alpha-fetoprotein anclior liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. Cochrane Database Syst. Rev (2003) 2:CD002799.
   Google Scholar
• COSGROVE DO, BLOMLEY MJ, ECKERSLEY RJ, HARVEY C: Innovative contrast specific imaging with ultrasound. Electromedica (2002) 70:147–149.
   Google Scholar
• SCHNEIDER M, ARDITI M, BARRAU MB et al: BR1: a new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles. Invest. Radial. (1995) 30:451–457.
   PubMed Web of Science ®Google Scholar
• MOREL DR, SCHWIEGER I, HOHN L et al.: Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest. Radial. (2000) 35:80–85.
   PubMed Web of Science ®Google Scholar
• CORREAS JM, BURNS PN, LAI X, QI X: Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1. Invest. Radial. (2000) 35:72–79.
   PubMed Web of Science ®Google Scholar
• CORREAS JM, BRIDAL L, LESAVRE A, MEJEAN A, CLAUDON M,HELENON 0: Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur. Radial. (2001) 11:1316–1328.
   PubMed Web of Science ®Google Scholar
• QUAIA E, CALLIADA F,BERTOLOTTO M et al.: Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnosticperformance and confidence. Radiology(2004) 232(2):420–430.
   Google Scholar
• TORZILLI G, OLIVARI N, MORONI E et al.: Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis. Liver Transpl (2004) 10(2 Supp1.1):34–38.
   Google Scholar
• TORZILLI G, DEL FABBRO D, OLIVARI N, CALLIADA F, MONTORSI M, MAKUUCHI M: Usefulness of contrast-enhanced intraoperative ultrasonography during surgery for liver lesion resection: preliminary report. Br. J. Surg. (2004) 91(9):1165–1167.
   PubMedGoogle Scholar
• EMEA REPORT, October 2004.
   Google Scholar
• FEDERLE MP, WILLIS LL,SWANSON DP: Ionic versus nonionic contrast media: a prospective study of the effect of rapid bolus injection on nausea and anaphylactoidreactions. I Comput. Assist. Tomogr.(1998) 22(3):341–345.
   PubMed Web of Science ®Google Scholar
• VALLS C, ANDIA E, SANCHEZ A, MORENO V: Selective use of low-osmolality contrast media in computed tomography. Eur. Radial. (2003) 13(8):2000–2005.
   PubMed Web of Science ®Google Scholar
• KATAYAMA H, YAMAGUCHI K, KOZUKA T, TAKASHIMA T, SEEZ P, MATSUURA K: Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology (1990) 175(3):621–628.
   Google Scholar
• COCHRAN ST, BOMYEA K, SAYRE JW: Trends in adverse events after IV administration of contrast media. AIR Am. Roentgenol (2001) 176(6):1385–1388.
   PubMed Web of Science ®Google Scholar
• MURPHY KJ, BRUNBERG JA, COHAN RH: Adverse reactions to gadolinium contrast media: a review of 36 cases. AIR Am. J. Roentgenol (1996) 167(4):847–849.
   PubMed Web of Science ®Google Scholar
• RUNGE VM: Safety of approved MR contrast media for intravenous injection. I Magn. Reson. Imaging (2000) 12(2):205–213.
   PubMedGoogle Scholar
• SPRING DB, BETTMANN MA, BARKAN HE: Deaths related to iodinated contrast media reported spontaneously tothe U.S. Food and Drug Administration, 1978–1994: effect of the availability of low-osmolality contrast media. Radiology (1997) 204(2):333–337.
   Google Scholar
• PESCHL R, WERLE A, MATHIS G: Differential diagnosis of focal liver lesions in signal-enhanced ultrasound using BR 1, a second-generation ultrasound signal enhancer. Dig. Dis. (2004) 22(1):73–80.
   PubMed Web of Science ®Google Scholar
• GIORGIO A, FERRAIOLI G,TARANTINO L et al: Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AIR Am. Roentgenol (2004) 183(5):1319–1326.
   PubMed Web of Science ®Google Scholar
• GAIANI S, CELLI N, PISCAGLIA F et al: Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. I Hepatol (2004) 41(3):421–426.
   Web of Science ®Google Scholar
• HOHMANN J, ALBRECHT T, OLDENBURG A, SKROK J, WOLF KJ: Liver metastases in cancer: detection with contrast-enhanced ultrasonography. Abdom. Imaging (2004) 29(6):669–681.
   PubMed Web of Science ®Google Scholar
• SAHANI DV, KALVA SP, TANABE KK et al: Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology (2004) 232(3):810–814.
   PubMed Web of Science ®Google Scholar
• DE GROOT MC,VAN GROOTHEEST AC: Letter 1: Contrast-enhanced ultrasonography during liver surgery. BE J. Surg. (2005) 92(1):121–122.
   PubMed Web of Science ®Google Scholar
• TORZILLI G: Letter 2: Contrast-enhanced ultrasonography during liver surgery. BE J. Surg. (2005) 92(1):22.
   Google Scholar